Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001346824-25-000068·Fulcrum Therapeutics, Inc.
Schedule 13G ownership disclosure
Fulcrum Therapeutics Inc
Common Stock, $0.001 par value per share · CUSIP: 359616109
Event date: 2025-12-08
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- RA Capital Management, L.P.
Shares: 6,053,960.00 · Class: 11.2%
- Peter Kolchinsky
Shares: 6,053,960.00 · Class: 11.2%
- Rajeev Shah
Shares: 6,053,960.00 · Class: 11.2%
- RA Capital Healthcare Fund, L.P.
Shares: 6,053,960.00 · Class: 11.2%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001346824-25-000068
- Form type
- SCHEDULE 13G/A
- Filer
- Fulcrum Therapeutics, Inc.
- CIK
- CIK 1680581
- Filed
- Dec 10, 2025
- Reporting period
- Dec 08, 2025
- Description
- Schedule 13G beneficial ownership